Inherited Blood Coagulation Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2022-03-21
EMA Authorised: NovoThirteen (catridecacog) — Novo Nordisk A/S
NovoThirteen (catridecacog) has been authorised by the EMA for inherited blood coagulation disorders.